Patents by Inventor David Selwood

David Selwood has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060100143
    Abstract: The invention relates to a polypeptide, or part thereof, which inhibits the apoptotic activity of the tumour suppressor protein p53 and including screening methods to identify agents which interfere with the activity of said polypeptide.
    Type: Application
    Filed: October 3, 2003
    Publication date: May 11, 2006
    Inventors: Xin Lu, Patricia Kuwabara, David Selwood
  • Patent number: 7009056
    Abstract: Compounds of formula (I), and pharmaceutically acceptable salts thereof, are capable of blockading voltage-dependent sodium channels and are useful in particular, in treating glaucoma and multiple sclerosis.
    Type: Grant
    Filed: February 5, 2001
    Date of Patent: March 7, 2006
    Assignee: University College London
    Inventors: Giti Garthwaite, David Selwood, Marcel Kling, Grant Wishart
  • Publication number: 20040054143
    Abstract: A peptide having part or all of the amino acid sequence QKRKRKKSRYKSWSVP (which is part of VEGF) has the ability to inhibit angiogenesis.
    Type: Application
    Filed: August 6, 2003
    Publication date: March 18, 2004
    Inventors: David Selwood, Ian Zachary, Haiyan Jia, Marianne Lohr, Dana Davis
  • Publication number: 20030171403
    Abstract: Compounds of formula (1), and pharmaceutically acceptable salts thereof, are capable of blockading voltage-dependent sodium channels and are useful in particular, in treating glaucoma and multiple sclerosis.
    Type: Application
    Filed: February 25, 2003
    Publication date: September 11, 2003
    Inventors: Giti Garthwaite, David Selwood, Marcel Kling, Grant Wishart